Clinical trial
Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk
NCT02313584 is registered in ClinicalTrials.gov with Korea University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk
- Lead sponsor
- Korea University
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- December 31, 2014
- Completion date
- September 30, 2017
- Enrollment
- 464 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.